These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 4598880)

  • 1. Activity of FL 1060, a new beta-lactam antibiotic, against urinary tract pathogens.
    Greenwood D; Brooks HL; Gargan R; O'Grady F
    J Clin Pathol; 1974 Mar; 27(3):192-7. PubMed ID: 4598880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro susceptibility of recent antibiotic-resistant urinary pathogens to ertapenem and 12 other antibiotics.
    Alhambra A; Cuadros JA; Cacho J; Gómez-Garcés JL; Alós JI
    J Antimicrob Chemother; 2004 Jun; 53(6):1090-4. PubMed ID: 15117925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prevalence of ampicillin, cephalosporin and sulphonamide resistance amongst urinary tract pathogens.
    Andrews J; Bywater MJ; Emmerson AM; Keane C; Reeves DS; Wise R
    Scott Med J; 1976 Sep; 20(5):232-5. PubMed ID: 772807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The comparative performance of beta-lactam antibiotics against ampicillin sensitive Escherichia coli in conditions simulating those of the infected urinary bladder.
    Greenwood D; O'Grady F
    Br J Exp Pathol; 1974 Jun; 55(3):245-50. PubMed ID: 4607731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The antibiotic sensitivity of 100 isolates of Escherichia coli, with special reference to the domiciliary treatment of urinary tract infections.
    Anderson K
    Med J Aust; 1970 Aug; 2(9):409-11. PubMed ID: 4924022
    [No Abstract]   [Full Text] [Related]  

  • 6. FL 1060: a new beta-lactam antibiotic with novel properties.
    Greenwood D; O'Grady F
    J Clin Pathol; 1973 Jan; 26(1):1-6. PubMed ID: 4348402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mecillinam activity compared to ampicillin, trimethoprim/sulfamethoxazole, ciprofloxacin and nitrofurantoin against urinary tract isolates of gram-negative bacilli.
    Zhanel GG; Karlowsky JA; Schwartz B; Jensen SB; Hoban DJ
    Chemotherapy; 1998; 44(6):391-6. PubMed ID: 9755298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prior antibiotics and risk of antibiotic-resistant community-acquired urinary tract infection: a case-control study.
    Hillier S; Roberts Z; Dunstan F; Butler C; Howard A; Palmer S
    J Antimicrob Chemother; 2007 Jul; 60(1):92-9. PubMed ID: 17540675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Profile of antimicrobial resistance of agents causing urinary tract infections in children].
    Ghedira Besbes L; Messaoudi A; Ben Meriem C; Guediche MN
    Tunis Med; 2004 Mar; 82(3):299-305. PubMed ID: 15382465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Spectrum of pathogens and resistance to antibiotics in urinary tract infections and the consequences for antibiotic treatment: study of urology inpatients with urinary tract infections (1994-2001)].
    Wagenlehner E; Niemetz A; Naber G
    Urologe A; 2003 Jan; 42(1):13-25. PubMed ID: 12574879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative study of Minocycline and Ampicillin in the treatment of urinary tract infections.
    Klastersky J; Daneau D
    Int J Clin Pharmacol; 1974 Mar; 9(2):125-31. PubMed ID: 4208030
    [No Abstract]   [Full Text] [Related]  

  • 12. Susceptibility to β-lactams and quinolones of Enterobacteriaceae isolated from urinary tract infections in outpatients.
    Marchisio M; Porto A; Joris R; Rico M; Baroni MR; Di Conza J
    Braz J Microbiol; 2015; 46(4):1155-9. PubMed ID: 26691475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bacteriological and clinical evaluation of the combination of cloxacillin with ampicillin.
    Klastersky J; Debusscher L; Rühl D
    Chemotherapy; 1972; 17(6):382-91. PubMed ID: 4628324
    [No Abstract]   [Full Text] [Related]  

  • 14. Response of ampicillin resistant Escherichia coli to cephalosporins in an in vitro model simulating conditions of bacterial growth in the urinary bladder.
    Greenwood D; O'Grady F
    Br J Exp Pathol; 1975 Apr; 56(2):167-71. PubMed ID: 1106751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activity of six beta-lactam antibiotics against non-beta-lactamase producing and producing enterobacteria and antibiotic resistance transfer.
    Scioli C; Esposito S; Martinelli R
    Boll Ist Sieroter Milan; 1984 Sep; 63(4):338-47. PubMed ID: 6335045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Resistance of clinical strains of Proteus to various beta-lactam antibiotics].
    Shvidenko IG
    Antibiotiki; 1976 Oct; 21(10):910-4. PubMed ID: 793508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibacterial compounds of Canadian honeys target bacterial cell wall inducing phenotype changes, growth inhibition and cell lysis that resemble action of β-lactam antibiotics.
    Brudzynski K; Sjaarda C
    PLoS One; 2014; 9(9):e106967. PubMed ID: 25191847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Analysis of anti-microbial resistance of Escherichia coli that caused infection in urogenital system].
    Cui WL; Xu DX; Li WL; Wang LX
    Di Yi Jun Yi Da Xue Xue Bao; 2004 Aug; 24(8):940-2, 945. PubMed ID: 15321769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population analysis of sensitivity to ampicillin and carbenicillin in Eschericia coli and Enterobacter cloacae.
    Søggard P
    Acta Pathol Microbiol Immunol Scand B; 1982 Jun; 90(3):235-41. PubMed ID: 6751021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Nitrofurans: a modern treatment for uncomplicated urinary infections?].
    Cahen P; Honderlick P
    Pathol Biol (Paris); 2000 Jun; 48(5):470-1. PubMed ID: 10949843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.